Clinical Trials Directory

Trials / Unknown

UnknownNCT02495272

Postpartum Uterotonic Administration

The Effect of the Timing of Uterotonic Administration in the Third Stage of Labour on Postpartum Hemorrhage

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
Bagcilar Training and Research Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The investigators are planning to determine the effect of the timing of oxytocin administration on the amount of blood loss, necessity for additional medical or surgical interventions.

Detailed description

The investigators are studying the effects of the timing of intramuscular oxytocin administration in the third stage of labour. The investigators are measuring the postpartum blood loss: quantitatively in the postpartum 1st hour and indirectly by the decrease in the hemoglobin-haematocrit levels in the postpartum 24th hour. The investigators are monitoring the length of the third stage of labour, and the need for extra uterotonics and/or surgical interventions.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinOxytocin 10IU Administered intramuscularly.

Timeline

Start date
2014-06-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2015-07-13
Last updated
2015-07-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02495272. Inclusion in this directory is not an endorsement.

Postpartum Uterotonic Administration (NCT02495272) · Clinical Trials Directory